Burrows Scott L

CIK 00018533272 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001853327

Recent Transactions

47 trades

Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-07-01$14.50/sh+7,500→ 105,494 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-07-01−7,500→ 352,357 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-07-01$88.37/sh−1,725→ 97,994 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-07-01$87.55/sh−5,775→ 99,719 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-25$87.12/sh−5,000→ 107,994 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-06-25−15,000→ 359,857 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-25$87.14/sh−10,000→ 97,994 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-25$14.50/sh+15,000→ 112,994 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-01$69.75/sh−1,801→ 103,693 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-06-01−7,500→ 374,857 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-01$72.06/sh−3,100→ 97,994 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-01$70.77/sh−2,599→ 101,094 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-01$14.50/sh+7,500→ 105,494 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-05-01$71.37/sh−12,500→ 97,994 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-05-01−12,500→ 382,357 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-05-01$14.50/sh+12,500→ 110,494 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-04-01$49.21/sh−6,200→ 99,294 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-04-01−7,500→ 394,857 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-04-01$49.98/sh−1,300→ 97,994 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-04-01$14.50/sh+7,500→ 105,494 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-03-03$14.50/sh+2,500→ 100,494 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-03-03$40.56/sh−2,300→ 98,194 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-03-03$41.66/sh−200→ 97,994 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-03-03−2,500→ 402,357 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-01-09+140,000→ 140,000 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2025-09-02$16.26/sh−18,428→ 97,994 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2025-01-15+95,500→ 95,500 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2024-09-03$28.17/sh−18,531→ 116,422 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2024-02-01+70,000→ 70,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Common Stock
2023-12-22+134,953→ 134,953 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2023-09-01+10,121,441→ 10,121,441 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-03-06$15.26/sh−291→ 59,115 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-03-02$15.82/sh−1,416→ 38,424 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2023-03-02+55,800→ 55,800 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-03-02+21,000→ 59,406 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-03-02$16.52/sh−18→ 38,406 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-02-28$16.17/sh−416→ 39,840 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2022-09-16−5,000→ 37,277 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-09-16$1.68/sh+5,000→ 40,256 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-03-07$16.44/sh−10→ 35,256 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-03-04$16.86/sh−293→ 35,266 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2022-03-03+35,300→ 35,300 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-03-03+13,300→ 35,559 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-03-01$17.75/sh−420→ 22,259 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-12-30+55,704→ 55,704 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-12-27$20.07/sh−12,560→ 22,679 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-04-01+23,000→ 23,000 total

Companies

Recent Filings

Address

221 CRESCENT STREET, BUILDING 23, SUITE 105

WALTHAM, MA, 02453

View on SEC.gov